ArticleMolecular medicine reports2016

miR-200c regulates crizotinib-resistant ALK-positive lung cancer cells by reversing epithelial-mesenchymal transition via targeting ZEB1.

Hai-Xiang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.